NCT00723008

Brief Summary

To find out if Cranial Electrotherapy Stimulation is a useful treatment for people who have been burned and have Post Traumatic Stress Disorder. CES may be helpful in giving relief to some or all of those symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started May 2007

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 25, 2007

Completed
7 months until next milestone

First Posted

Study publicly available on registry

July 28, 2008

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

March 22, 2013

Completed
Last Updated

March 22, 2013

Status Verified

February 1, 2013

Enrollment Period

3.1 years

First QC Date

December 25, 2007

Results QC Date

October 9, 2012

Last Update Submit

February 19, 2013

Conditions

Keywords

anxietyinsomniapainAlpha StimCranial electrotherapy stimulation

Outcome Measures

Primary Outcomes (6)

  • Mean Post-Traumatic Stress Questionnaire-Military (PCL-M) Score

    Subjects were asked to complete questionnaire three times during the course of study. Questions addressed symptoms associated with Post Traumatic Stress Disorder(PTSD). Scores can range from 17 to 85. A score \>31 was used to identify symptomatic subjects and was therefore required at baseline for study enrollment.

    Baseline, Week 4, Week 8

  • Mean Center for Epidemiological Studies-Depression Scale (CES-D) Score

    This 20-item questionnaire measures depressive symptoms. Scores can range from 0-60, with scores greater than 16 indicating need for further evaluation due to possible Major Depression.

    Baseline, 4 Weeks, 8 Weeks

  • Mean Brief Profile of Mood States (BPOMS) Score

    BPOMS is a tool used to qualitatively measure anxiety. Subjects were asked to evaluate 30 feelings that they may have had over the past week. Stress-associated feelings are scored on a 5-point Likert scale from 0 (not at all)to 4 (extremely). Six of the feelings listed on the questionnaire are not associated with anxiety and therefore are not scored. Total scores range from 0-96, with higher scores indicating greater tension and anxiety.

    Baseline, Week 4, Week 8

  • Mean Visual Analogue Scale of Pain (VAS-P) Before and After Cranial Electrotherapy Stimulation (CES).

    Subjects were asked to evaluate their pain intensity before and after each daily CES or sham treatment. Responses were scored on a scale ranging from 0 (indicating no pain) to 10 (worst possible pain).

    Blinded Period, Unblinded Period

  • Mean Visual Analogue Scale of Anxiety (VAS-A) Before and After Cranial Electrotherapy Stimulation (CES).

    Subjects were asked to evaluate their anxiety level before and after each daily CES treatment. Responses were scored on a scale ranging from 0 (indicating no anxiety) to 10 (worst possible).

    Blinded Period, Unblinded Period

  • Mean General Sleep Disturbance Scale (GSDS) Score

    The GSDS is a questionnaire used to qualitatively evaluate sleep. This 21-question tool evaluates each aspect of sleep and restfulness on a 0-7 score, indicating the number of days per week that each problem may be present. Total scores range from 0-147, with higher scores indicating more profound disturbances in sleep.

    Baseline, Week 4, Week 8

Study Arms (2)

A

EXPERIMENTAL

Upon randomization, a double blinded Alpha Stim 100 device preset to the lowest effective setting (1/6) will be applied to the earlobes of the subject for one hour per day for 5 days per week for 4 weeks; after the blinded period is completed the patient will wear a different Alpha Stim device that has not been blinded for one hour per day for 5 days per week for 4 weeks, with settings at the patient's preference (1 to 6/6). Report of pain, anxiety will be assessed before and after each daily session during the 8 week period.

Device: Alpha Stim 100 (Cranial Electrotherapy Stimulation)

B

EXPERIMENTAL

Upon randomization, a double blinded Alpha Stim 100 device preset to no stimulation (0/6)will be applied to the earlobes of the subject for one hour per day for 5 days per week for 4 weeks; after the blinded period is completed the patient will wear a different Alpha Stim device that has not been blinded for one hour per day for 5 days per week for 4 weeks, with settings at the patient's preference (1 to 6/6). Report of pain, anxiety will be assessed before and after each daily session during the 8 week period.

Device: Alpha Stim 100 (Cranial Electrotherapy Stimulation)

Interventions

cranial electrical stimulation 100 microamps

Also known as: Alpha Stim 100- Electromedical Products International, Inc
AB

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • burned patients requiring outpatient physical or occupational therapy in the USAISR Burn Rehabilitation Gym or Center for the Intrepid
  • Able to read and speak English
  • Between ages of 18-65 years
  • Screen positive (score greater than 44) on the PCL-M/C instruments

You may not qualify if:

  • pregnant patients
  • patients with implantable pacemakers or electronic stimulators
  • patients scoring below 44 on the PCL-M/C instrument
  • patients who previously used CES therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USAISR

Fort Sam Houston, Texas, 78234, United States

Location

Related Publications (1)

  • Schroeder MJ, Barr RE. Quantitative analysis of the electroencephalogram during cranial electrotherapy stimulation. Clin Neurophysiol. 2001 Nov;112(11):2075-83. doi: 10.1016/s1388-2457(01)00657-5.

    PMID: 11682346BACKGROUND

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticBurnsAnxiety DisordersSleep Initiation and Maintenance DisordersPain

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersWounds and InjuriesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

This study had a high study turn-over rate, which led to small data group analysis. All subjects enrolled were active military service men. This made civilian and female comparison impossible. The PI also changed during study course.

Results Point of Contact

Title
LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS
Organization
U.S. Army Institute of Surgical Research

Study Officials

  • Kathryn Gaylord, RN, MSN, PhD

    United States Army Institute of Surgical Research

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 25, 2007

First Posted

July 28, 2008

Study Start

May 1, 2007

Primary Completion

June 1, 2010

Study Completion

December 1, 2010

Last Updated

March 22, 2013

Results First Posted

March 22, 2013

Record last verified: 2013-02

Locations